March 23, 2016
Quanterix announces it has secured $46 million in Series D funding from both new and existing investors. This infusion of capital will allow Quanterix to build on the significant growth realized in the last two years.
March 8, 2016
Quanterix announces that Kevin Hrusovsky, Executive Chairman and CEO, will present at the Cowen and Company 36th Annual Health Care Conference.
March 1, 2016
Quanterix announces that it has been selected by Fast Company as one of the world’s top 10 most innovative companies in 2016 in Sports – the only medical technology company to be recognized in this category.
Quanterix Names Frontage Laboratories as a Preferred Partner in Biomarker Assay Development and Testing Services in the Regulated Space
February 10, 2016
Quanterix announces an alliance with Frontage Laboratories, naming the Company as a Preferred Partner for assay research and development. Leveraging Simoa’s sensitivity and revolutionary digital approach for assay development and research, Frontage will have the ability to enter new markets and…
February 9, 2016
Quanterix announces that Analytical Chemistry, a leading peer-reviewed scientific journal, has published a truly groundbreaking new study authored by Dr. David Walt of Tufts University that prominently features Quanterix’s Single Molecule Array Detection technology, Simoa.
Quanterix Presented Ultrasensitive Technology at NFL Health and Safety Update & Interactive Head Health Showcase
February 5, 2016
Quanterix announces that is participating in the NFL Health and Safety Update & Interactive Head Health Showcase at Super Bowl 50.
January 27, 2016
Quanterix announces its expansion into several prominent APAC markets.
ABL, Inc. Offers Quanterix Diagnostic Platform for Ultrasensitive Biomarker Detection Through Platine Pharma Services Subsidiary
January 14, 2016
Platine Pharma Services SAS (PPS), a majority owned subsidiary of ABL, Inc., is a preferred partner with Quanterix Corporation, providing new ultrasensitive assays using the single molecule measurement digital platform, Simoa.
January 11, 2016
Quanterix announces that it will be presenting at the 34th Annual J.P. Morgan Healthcare Conference in San Francisco, California.
Quanterix Teams Up with Global Leaders to Establish a Groundbreaking Vision for Early Disease Detection, Prevention and Precision Drug Development to Revolutionize Healthcare
December 2, 2015
Quanterix announces the success of the company’s recent user conference entitled, “Proteins Powering NextGen Healthcare: San Francisco.”